Kimball Electronics, Inc. KE
Kimball Electronics was founded in 1961 and incorporated in 1998. We deliver a package of value that includes durable, high-reliability electronics, higher level and final assemblies, and contract development and manufacturing organization ("CDMO") solutions. Through our Kimball Solutions platform, we provide integrated manufacturing solutions that combine electronics manufacturing services, medical disposables, drug delivery solutions, precision molded plastics, and end-to-end product lifecycle support. Our CDMO solutions support the production of medical disposables and drug delivery devices, from precision molded plastics and cold chain management to drug integration. The acquisition of Helvoet Polymer Technologies B.V. ("Helvoet") on July 1, 2026, which occurred after our fiscal year end and is therefore reported as a subsequent event in Note 22 - Subsequent Event of Notes to Consolidated Financial Statements, expanded our capabilities in precision molded plastics, complex tooling, and medical device component manufacturing, enhancing our ability to provide comprehensive solutions to customers across the medical and pharmaceutical markets. Customers and industry trade publications regularly award us for our design, engineering, and manufacturing expertise that, coupled with robust processes and procedures, help us ensure that we deliver the highest levels of quality, reliability, and innovative service throughout the entire life cycle of our customers' products. Our Customer Relationship Management ("CRM") model is key to providing our customers convenient access to our highly integrated global footprint, enabled by our largely standardized operating system and procedures.
Valuation FY2026 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.43B | $1.49B | $1.71B | $1.82B | $1.35B | $1.29B | $1.20B | $1.18B | $1.07B | $930.9M |
| Cost of revenue | $1.31B | $1.38B | $1.57B | $1.67B | $1.24B | $1.17B | $1.12B | $1.09B | $986.0M | $855.5M |
| Gross profit | $117.5M | $104.4M | $140.3M | $156.2M | $104.6M | $118.0M | $83.8M | $88.4M | $86.0M | $75.4M |
| SG&A | $61.2M | $50.3M | $66.6M | $68.6M | $53.4M | $52.7M | $43.9M | $46.7M | $44.0M | $36.7M |
| Operating income | $66.1M | $45.5M | $49.3M | $87.7M | $52.5M | $65.7M | $32.0M | $42.1M | $42.0M | $42.8M |
| Interest expense | $8.5M | $14.7M | $22.8M | $16.3M | $2.7M | $2.2M | $4.4M | $4.1M | $527.0K | $271.0K |
| Pre-tax income | $53.2M | $26.2M | $25.2M | $74.7M | $43.7M | $70.1M | $25.2M | $38.5M | $44.8M | $44.3M |
| Income tax | $25.3M | $9.2M | $4.7M | $18.9M | $12.5M | $13.3M | $7.0M | $6.9M | $28.0M | $10.1M |
| Net income | $28.0M | $17.0M | $20.5M | $55.8M | $31.3M | $56.8M | $18.2M | $31.6M | $16.8M | $34.2M |
| EPS, basic | 1.14 | 0.68 | 0.82 | 2.24 | 1.24 | 2.26 | 0.72 | 1.22 | 0.63 | 1.25 |
| EPS, diluted | 1.13 | 0.68 | 0.81 | 2.22 | 1.24 | 2.24 | 0.71 | 1.21 | 0.62 | 1.24 |
| Shares, diluted (wtd. avg.) | $24.8M | $25.0M | $25.3M | $25.1M | $25.2M | $25.3M | $25.4M | $26.1M | $27.0M | $27.5M |
Balance sheet
| Fiscal year | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $88.9M | $88.8M | $78.0M | $43.9M | $49.9M | $106.4M | $65.0M | $49.3M | $46.4M | $44.6M |
| Receivables | $218.8M | $222.6M | $282.3M | $308.2M | $222.9M | $203.4M | $180.1M | $225.6M | $173.6M | $169.8M |
| Inventory | $271.9M | $273.5M | $338.1M | $450.3M | $395.6M | $200.4M | $219.0M | $203.8M | $201.6M | $144.6M |
| Total current assets | $693.0M | $699.6M | $847.0M | $929.4M | $761.1M | $583.4M | $558.4M | $555.3M | $437.0M | $388.2M |
| Property, plant and equipment | $274.2M | $264.8M | $269.7M | $267.7M | $206.8M | $163.3M | $154.5M | $143.6M | $137.2M | $137.5M |
| Goodwill | $6.2M | $6.2M | $6.2M | $12.0M | $12.0M | $12.0M | $12.0M | $18.1M | $6.2M | $6.2M |
| Other intangibles | $1.9M | $2.4M | $3.0M | $12.3M | $14.7M | $17.0M | $19.3M | $22.2M | $4.4M | $4.6M |
| Total assets | $1.09B | $1.08B | $1.21B | $1.26B | $1.04B | $814.1M | $774.8M | $764.1M | $608.8M | $554.9M |
| Accounts payable | $234.4M | $218.8M | $213.6M | $322.3M | $300.2M | $216.5M | $203.7M | $197.0M | $187.8M | $154.6M |
| Total current liabilities | $332.1M | $318.6M | $375.3M | $475.1M | $408.7M | $300.8M | $272.6M | $274.9M | $228.6M | $199.2M |
| Long-term debt | $116.2M | $147.1M | $294.8M | — | — | — | — | — | — | — |
| Total liabilities | — | — | — | — | — | — | — | — | — | $212.7M |
| Retained earnings | $361.5M | $333.5M | $316.6M | $296.1M | $240.2M | $209.0M | $152.2M | $134.0M | $99.4M | $82.7M |
| Total equity | $585.1M | $569.9M | $540.5M | $524.0M | $454.0M | $442.0M | $379.4M | $369.9M | $355.5M | $342.3M |
Cash flow
| Fiscal year | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $72.3M | $183.9M | $73.2M | -$13.8M | -$83.2M | $130.1M | $72.8M | -$6.7M | $40.2M | $46.8M |
| Depreciation and amortisation | $38.7M | $37.0M | $38.0M | $32.4M | $29.4M | $34.0M | $30.9M | $28.9M | $26.4M | $23.9M |
| Stock-based compensation | $8.2M | $6.5M | $7.2M | $6.9M | $6.2M | $3.9M | $4.0M | $5.7M | $5.3M | $3.5M |
| Capital expenditure | $51.5M | $33.3M | $46.1M | $89.4M | $74.0M | $38.4M | $38.4M | $24.7M | $25.9M | $33.3M |
| Investing cash flow | -$25.9M | -$14.7M | -$46.5M | -$90.5M | -$74.8M | -$38.8M | -$38.5M | -$68.7M | -$26.2M | -$35.7M |
| Financing cash flow | -$47.0M | -$160.9M | $9.0M | $99.2M | $103.7M | -$53.1M | -$17.9M | $79.4M | -$12.6M | -$22.0M |
| Buybacks | $11.9M | $12.0M | $2.8M | $0 | $9.0M | $3.0M | $8.8M | $23.4M | $9.6M | $22.3M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001606757-26-000032.
Others in SIC 3672
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| FLEX | FLEX LTD. | $40.45B | 47.0x | 8.1% |
| CLS | CELESTICA INC | $35.91B | 43.6x | 28.5% |
| JBL | JABIL INC | $32.54B | 52.5x | 3.2% |
| TTMI | TTM TECHNOLOGIES INC | $13.23B | 74.8x | 19.0% |
| SANM | SANMINA CORP | $10.64B | 44.5x | 7.4% |
| PLXS | PLEXUS CORP | $6.56B | 39.3x | 1.8% |
| BHE | BENCHMARK ELECTRONICS INC | $2.61B | 106.8x | -0.4% |
| CTS | CTS CORP | $1.63B | 26.1x | 5.2% |